Cytokinetics, Incorporated

Cytokinetics, Incorporatedverified

CYTK

Price:

$51.82

Market Cap:

$6.10B

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activa...[Read more]

Industry

Biotechnology

IPO Date

2004-04-30

Stock Exchange

NASDAQ

Ticker

CYTK

The Dividend Yield as of November 2024 (TTM) for Cytokinetics, Incorporated (CYTK) is 0%

According to Cytokinetics, Incorporated’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Cytokinetics, Incorporated (CYTK) Historical Dividend Yield (quarterly & annually)

How has CYTK Dividend Yield performed in the past?

The mean historical Dividend Yield of Cytokinetics, Incorporated over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), CYTK's Dividend Yield was at its highest in in the September 2014 quarter at 0%. The Dividend Yield was at its lowest in in the September 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Cytokinetics, Incorporated (CYTK) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Cytokinetics, Incorporated Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%
20140%0%

Cytokinetics, Incorporated (CYTK) Average Dividend Yield

How has CYTK Dividend Yield performed in the past?

The current Dividend Yield of Cytokinetics, Incorporated (CYTK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Cytokinetics, Incorporated (CYTK) Dividend Yield vs. Peers

How is CYTK’s Dividend Yield compared to its peers?

Cytokinetics, Incorporated’s Dividend Yield is less than DICE Therapeutics, Inc. (0%), less than Edgewise Therapeutics, Inc. (0%), less than Karuna Therapeutics, Inc. (0%), less than Dyne Therapeutics, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Pliant Therapeutics, Inc. (0%), less than Revolution Medicines, Inc. (0%), less than Relay Therapeutics, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than Arvinas, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Amylyx Pharmaceuticals, Inc. (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Blueprint Medicines Corporation (0%),

Build a custom stock screener for Cytokinetics, Incorporated (CYTK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytokinetics, Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cytokinetics, Incorporated (CYTK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cytokinetics, Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Cytokinetics, Incorporated's Dividend Yield?

How is the Dividend Yield calculated for Cytokinetics, Incorporated (CYTK)?

What is the highest Dividend Yield for Cytokinetics, Incorporated (CYTK)?

What is the 3-year average Dividend Yield for Cytokinetics, Incorporated (CYTK)?

What is the 5-year average Dividend Yield for Cytokinetics, Incorporated (CYTK)?

How does the current Dividend Yield for Cytokinetics, Incorporated (CYTK) compare to its historical average?